ReP USP - Resultado da busca

Artigo de periodico
Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer (2023)
Fukumori, Claudio ; Branco, Paola Cristina ; Barreto, Thayná ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, MICROBIOLOGIA, NEOPLASIAS COLORRETAIS, ANTINEOPLÁSICOS, QUIMIOTERAPIA, CITOTOXINAS, GORDURAS, ALGINATOS, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUKUMORI, Claudio et al. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, v. 187, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106465. Acesso em: 11 jun. 2024.
APA
Fukumori, C., Branco, P. C., Barreto, T., Ishida, K., & Lopes, L. B. (2023). Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, 187, 1-15. doi:10.1016/j.ejps.2023.106465
NLM
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Vancouver
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Artigo de periodico
Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach (2023)
Miyagi, Mariana Yasue Saito ; Faria, Rafael de Oliveira; Lameu, Claudiana ; Souza, Gabriel Batista de; Tagami, Tatsuaki; Ozeki, Tetsuya; Bezzon, Vinícius Danilo Nonato ; Yukuyama, Megumi Nishitani ; Bou-Chacra, Nadia Araci ; Araujo, Gabriel Lima Barros de
Source: International Journal of Pharmaceutics. Unidade: FCF
Subjects: QUIMIOTERAPIA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAGI, Mariana Yasue Saito et al. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, v. 644, p. 1-13 art. 123324, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123324. Acesso em: 11 jun. 2024.
APA
Miyagi, M. Y. S., Faria, R. de O., Lameu, C., Souza, G. B. de, Tagami, T., Ozeki, T., et al. (2023). Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach. International Journal of Pharmaceutics, 644, 1-13 art. 123324. doi:10.1016/j.ijpharm.2023.123324
NLM
Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
Vancouver
Miyagi MYS, Faria R de O, Lameu C, Souza GB de, Tagami T, Ozeki T, Bezzon VDN, Yukuyama MN, Bou-Chacra NA, Araujo GLB de. Optimizing adjuvant inhaled chemotherapy: synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach [Internet]. International Journal of Pharmaceutics. 2023 ; 644 1-13 art. 123324.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123324
Artigo de periodico
Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview (2023)
Castro, Karine Cappuccio de ; Coco, Julia Cedran ; Santos, Érica Mendes dos; Ataide, Janaína Artem ; Martinez, Renata Miliani ; Nascimento, Monica Helena Monteiro do; Prata, João; Fonte, Pedro Ricardo Martins Lopes da; Severino, Patrícia; Mazzola, Priscila Gava; Baby, André Rolim ; Souto, Eliana Barbosa; Araujo, Daniele Ribeiro de; Lopes, André Moreni
Source: Journal of Controlled Release. Unidade: FCF
Subjects: QUIMIOTERAPIA, RADIOTERAPIA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Karine Cappuccio de et al. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview. Journal of Controlled Release, v. 353, p. 802-822, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2022.12.017. Acesso em: 11 jun. 2024.
APA
Castro, K. C. de, Coco, J. C., Santos, É. M. dos, Ataide, J. A., Martinez, R. M., Nascimento, M. H. M. do, et al. (2023). Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview. Journal of Controlled Release, 353, 802-822. doi:10.1016/j.jconrel.2022.12.017
NLM
Castro KC de, Coco JC, Santos ÉM dos, Ataide JA, Martinez RM, Nascimento MHM do, Prata J, Fonte PRML da, Severino P, Mazzola PG, Baby AR, Souto EB, Araujo DR de, Lopes AM. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview [Internet]. Journal of Controlled Release. 2023 ; 353 802-822.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jconrel.2022.12.017
Vancouver
Castro KC de, Coco JC, Santos ÉM dos, Ataide JA, Martinez RM, Nascimento MHM do, Prata J, Fonte PRML da, Severino P, Mazzola PG, Baby AR, Souto EB, Araujo DR de, Lopes AM. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview [Internet]. Journal of Controlled Release. 2023 ; 353 802-822.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jconrel.2022.12.017
Artigo de periodico
Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years (2022)
D'Angelo, Natália A ; Noronha, Mariana Akemi ; Câmara, Mayra C. C; Kurnik, Isabelle S ; Feng, Chuying; Araújo, Victor Hugo Sousa; Santos, João Henrique Picado Madalena ; Feitosa, Valker Araujo ; Molino, João Vitor Dutra ; Rangel-Yagui, Carlota de Oliveira ; Chorilli, Marlus ; Ho, Emmanuel A ; Lopes, André Moreni
Source: Materials Science & Engineering C. Unidade: FCF
Subjects: QUIMIOTERAPIA, ANTINEOPLÁSICOS, NEOPLASIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
D'ANGELO, Natália A et al. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C, v. 133, p. 1-23 art. 112623, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2021.112623. Acesso em: 11 jun. 2024.
APA
D'Angelo, N. A., Noronha, M. A., Câmara, M. C. C., Kurnik, I. S., Feng, C., Araújo, V. H. S., et al. (2022). Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years. Materials Science & Engineering C, 133, 1-23 art. 112623. doi:10.1016/j.msec.2021.112623
NLM
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2022 ; 133 1-23 art. 112623.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.msec.2021.112623
Vancouver
D'Angelo NA, Noronha MA, Câmara MCC, Kurnik IS, Feng C, Araújo VHS, Santos JHPM, Feitosa VA, Molino JVD, Rangel-Yagui C de O, Chorilli M, Ho EA, Lopes AM. Doxorubicin nanoformulations on therapy against cancer: an overview from the last 10 years [Internet]. Materials Science & Engineering C. 2022 ; 133 1-23 art. 112623.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.msec.2021.112623
Artigo de periodico
Required time for pre-oncological dental management: a rapid review of the literature (2022)
Mazzetti, Thais ; Santos, Paulo Sérgio da Silva ; Antunes, Héliton Spindola ; Montagner, Anelise Fernandes ; Van de Sande, Françoise Hélène ; Maske, Tamires Timm
Source: Oral Oncology. Unidade: FOB
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS, TRATAMENTO ODONTOLÓGICO, RADIOTERAPIA, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZZETTI, Thais et al. Required time for pre-oncological dental management: a rapid review of the literature. Oral Oncology, v. No 2022, p. 4 , 2022Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2022.106116. Acesso em: 11 jun. 2024.
APA
Mazzetti, T., Santos, P. S. da S., Antunes, H. S., Montagner, A. F., Van de Sande, F. H., & Maske, T. T. (2022). Required time for pre-oncological dental management: a rapid review of the literature. Oral Oncology, No 2022, 4 . doi:10.1016/j.oraloncology.2022.106116
NLM
Mazzetti T, Santos PS da S, Antunes HS, Montagner AF, Van de Sande FH, Maske TT. Required time for pre-oncological dental management: a rapid review of the literature [Internet]. Oral Oncology. 2022 ; No 2022 4 .[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.106116
Vancouver
Mazzetti T, Santos PS da S, Antunes HS, Montagner AF, Van de Sande FH, Maske TT. Required time for pre-oncological dental management: a rapid review of the literature [Internet]. Oral Oncology. 2022 ; No 2022 4 .[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.106116
Artigo de periodico
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 (2022)
Rischin, Danny; Harrington, Kevin J; Greil, Richard; Soulieres, Denis; Tahara, Makoto; Castro Junior, Gilberto de Castro ; Psyrri, Amanda; Brana, Irene; Neupane, Prakash; Bratland, Ase
Source: Oral oncology. Unidade: FM
Subjects: RECIDIVA LOCAL DE NEOPLASIA, NEOPLASIAS DE CABEÇA E PESCOÇO, RECIDIVA LOCAL DE NEOPLASIA, ENSAIO CLÍNICO, QUIMIOTERAPIA, IMUNOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RISCHIN, Danny et al. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, v. 128, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2022.105815. Acesso em: 11 jun. 2024.
APA
Rischin, D., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., Castro Junior, G. de C., et al. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral oncology, 128. doi:10.1016/j.oraloncology.2022.105815
NLM
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Vancouver
Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, Castro Junior G de C, Psyrri A, Brana I, Neupane P, Bratland A. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 [Internet]. Oral oncology. 2022 ; 128[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2022.105815
Artigo de periodico
Mathematical model of brain tumour growth with drug resistance (2021)
Trobia, José; Tian, Kun; Batista, Antonio ; Grebogi, Celso; Ren, Hai-Peng; Santos, Moises S.; Protachevicz, R. P. ; Borges, Fernando S.; Szezech, Jose Danilo ; Viana, Ricardo L.; Caldas, Iberê Luiz ; Iarosz, Kelly C.
Source: Communications in Nonlinear Science and Numerical Simulation. Unidade: IF
Subjects: FÍSICA MATEMÁTICA, BIOFÍSICA, GLIOMA, QUIMIOTERAPIA, NEOPLASIAS CEREBRAIS, EQUAÇÕES DIFERENCIAIS DA FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TROBIA, José et al. Mathematical model of brain tumour growth with drug resistance. Communications in Nonlinear Science and Numerical Simulation, v. 103, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.cnsns.2021.106013. Acesso em: 11 jun. 2024.
APA
Trobia, J., Tian, K., Batista, A., Grebogi, C., Ren, H. -P., Santos, M. S., et al. (2021). Mathematical model of brain tumour growth with drug resistance. Communications in Nonlinear Science and Numerical Simulation, 103. doi:10.1016/j.cnsns.2021.106013
NLM
Trobia J, Tian K, Batista A, Grebogi C, Ren H-P, Santos MS, Protachevicz RP, Borges FS, Szezech JD, Viana RL, Caldas IL, Iarosz KC. Mathematical model of brain tumour growth with drug resistance [Internet]. Communications in Nonlinear Science and Numerical Simulation. 2021 ; 103[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.cnsns.2021.106013
Vancouver
Trobia J, Tian K, Batista A, Grebogi C, Ren H-P, Santos MS, Protachevicz RP, Borges FS, Szezech JD, Viana RL, Caldas IL, Iarosz KC. Mathematical model of brain tumour growth with drug resistance [Internet]. Communications in Nonlinear Science and Numerical Simulation. 2021 ; 103[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.cnsns.2021.106013
Artigo de periodico
Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells (2021)
Vicari, Hugo Passos ; Lima, Keli ; Gomes, Ralph da Costa ; Fernandes, Daniara Cristina ; Silva, Jean Carlos Lipreri da ; Rodrigues Junior, Manoel Trindade; Oliveira, Aline Silva Barroso de; Santos, Ricardo Nascimento dos ; Andricopulo, Adriano Defini ; Coelho, Fernando; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho
Source: European Journal of Pharmacology. Unidades: IFSC, ICB
Subjects: FARMACOLOGIA, QUIMIOTERAPIA, LEUCEMIA MIELOIDE AGUDA, CÉLULAS SANGUÍNEAS, ANTINEOPLÁSICOS, ONCOGENES, CITOTOXICIDADE IMUNOLÓGICA, LEUCÓCITOS, PROLIFERAÇÃO CELULAR, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells. European Journal of Pharmacology, v. 894, p. 173853-1-173853-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2021.173853. Acesso em: 11 jun. 2024.
APA
Vicari, H. P., Lima, K., Gomes, R. da C., Fernandes, D. C., Silva, J. C. L. da, Rodrigues Junior, M. T., et al. (2021). Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells. European Journal of Pharmacology, 894, 173853-1-173853-10. doi:10.1016/j.ejphar.2021.173853
NLM
Vicari HP, Lima K, Gomes R da C, Fernandes DC, Silva JCL da, Rodrigues Junior MT, Oliveira ASB de, Santos RN dos, Andricopulo AD, Coelho F, Lotufo LVC, Machado Neto JA. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells [Internet]. European Journal of Pharmacology. 2021 ; 894 173853-1-173853-10.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2021.173853
Vancouver
Vicari HP, Lima K, Gomes R da C, Fernandes DC, Silva JCL da, Rodrigues Junior MT, Oliveira ASB de, Santos RN dos, Andricopulo AD, Coelho F, Lotufo LVC, Machado Neto JA. Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells [Internet]. European Journal of Pharmacology. 2021 ; 894 173853-1-173853-10.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2021.173853
Artigo de periodico
Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention (2021)
Apolinário, Alexsandra Conceição ; Hauschke, Leon; Nunes, Jessica Ribeiro ; Lourenço, Felipe Rebello ; Lopes, Luciana Biagini
Source: Colloids and Surfaces A. Unidades: FCF, ICB
Subjects: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA, QUIMIOTERÁPICOS, SOLUBILIDADE, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, v. 623, n. 20, p. 1-14 art. 126745, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2021.126745. Acesso em: 11 jun. 2024.
APA
Apolinário, A. C., Hauschke, L., Nunes, J. R., Lourenço, F. R., & Lopes, L. B. (2021). Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention. Colloids and Surfaces A, 623( 20), 1-14 art. 126745. doi:10.1016/j.colsurfa.2021.126745
NLM
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Vancouver
Apolinário AC, Hauschke L, Nunes JR, Lourenço FR, Lopes LB. Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention [Internet]. Colloids and Surfaces A. 2021 ; 623( 20): 1-14 art. 126745.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.colsurfa.2021.126745
Artigo de periodico
Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma (2021)
Tedesco, Antônio Cláudio ; Silva, Emanoel Pedro de Oliveira; Jayme, Cristiano Ceron ; Piva, Henrique Luis ; Franchi, Leonardo Pereira
Source: Materials Science and Engineering: C. Unidade: FFCLRP
Subjects: TERAPIA FOTODINÂMICA, NEOPLASIAS CEREBRAIS, COLESTEROL, EMULSÕES (FORMAS FARMACÊUTICAS), QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEDESCO, Antônio Cláudio et al. Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma. Materials Science and Engineering: C, v. 123, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2021.111984. Acesso em: 11 jun. 2024.
APA
Tedesco, A. C., Silva, E. P. de O., Jayme, C. C., Piva, H. L., & Franchi, L. P. (2021). Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma. Materials Science and Engineering: C, 123. doi:10.1016/j.msec.2021.111984
NLM
Tedesco AC, Silva EP de O, Jayme CC, Piva HL, Franchi LP. Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma [Internet]. Materials Science and Engineering: C. 2021 ; 123[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.msec.2021.111984
Vancouver
Tedesco AC, Silva EP de O, Jayme CC, Piva HL, Franchi LP. Cholesterol-rich nanoemulsion (LDE) as a novel drug delivery system to diagnose, delineate, and treat human glioblastoma [Internet]. Materials Science and Engineering: C. 2021 ; 123[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.msec.2021.111984
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 11 jun. 2024.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments (2020)
Furlan, João Pedro Rueda ; Savazzi, Eduardo Angelino; Stehling, Eliana Guedes
Source: International Journal of Antimicrobial Agents. Unidade: FCFRP
Subjects: INFECÇÕES BACTERIANAS, BACTÉRIAS, ESCHERICHIA COLI, FARMACOLOGIA, QUIMIOTERAPIA, GENOMAS, PLASMÍDEOS, TESTES DE SENSIBILIDADE MICROBIANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURLAN, João Pedro Rueda e SAVAZZI, Eduardo Angelino e STEHLING, Eliana Guedes. Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments. International Journal of Antimicrobial Agents, v. 56, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijantimicag.2020.106040. Acesso em: 11 jun. 2024.
APA
Furlan, J. P. R., Savazzi, E. A., & Stehling, E. G. (2020). Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments. International Journal of Antimicrobial Agents, 56( 1). doi:10.1016/j.ijantimicag.2020.106040
NLM
Furlan JPR, Savazzi EA, Stehling EG. Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments [Internet]. International Journal of Antimicrobial Agents. 2020 ; 56( 1):[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijantimicag.2020.106040
Vancouver
Furlan JPR, Savazzi EA, Stehling EG. Widespread high-risk clones of multidrug-resistant extended-spectrum β-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments [Internet]. International Journal of Antimicrobial Agents. 2020 ; 56( 1):[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ijantimicag.2020.106040
Artigo de periodico
Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts (2020)
Figaro-Drumond, Fernanda Viana; Pereira, Sherliane Carla ; Menezes, Itiana Castro; Baes, Cristiane Von Werne ; Coeli-Lacchini, Fernanda Borchers ; Oliveira-Paula, Gustavo Henrique; Cleare, Anthony J.; Young, Allan H.; Tanus-Santos, José Eduardo ; Juruena, Mário Francisco Pereira; Lacchini, Riccardo
Source: Behavioural Brain Research. Unidades: EERP, FMRP
Subjects: ANTIDEPRESSIVOS, USOS TERAPÊUTICOS, ESTUDOS DE CASOS E CONTROLES, QUIMIOTERAPIA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, SISTEMA HIPOTÁLAMO-HIPOFISÁRIO, POLIMORFISMO, TENTATIVA DE SUICÍDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGARO-DRUMOND, Fernanda Viana et al. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, v. 81, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2019.112343. Acesso em: 11 jun. 2024.
APA
Figaro-Drumond, F. V., Pereira, S. C., Menezes, I. C., Baes, C. V. W., Coeli-Lacchini, F. B., Oliveira-Paula, G. H., et al. (2020). Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts. Behavioural Brain Research, 81. doi:10.1016/j.bbr.2019.112343
NLM
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Vancouver
Figaro-Drumond FV, Pereira SC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Oliveira-Paula GH, Cleare AJ, Young AH, Tanus-Santos JE, Juruena MFP, Lacchini R. Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts [Internet]. Behavioural Brain Research. 2020 ; 81[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.bbr.2019.112343
Trabalho de evento-resumo periodico
Evaluation of food intake in women in chemotherapy for breast cancer (2020)
Rufato, Sarah Carreira; Silva, B. R. da; Cruz, L. P. da; Mialich, Mirele Savegnago; Gozzo, Thais de Oliveira ; Jordão, A. A.
Source: Clinical Nutrition ESPEN. Conference titles: ESPEN Virtual Congress on Clinical Nutrition & Metabolism. Unidades: EERP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, ALIMENTAÇÃO, MULHERES, ESTADO NUTRICIONAL, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUFATO, Sarah Carreira et al. Evaluation of food intake in women in chemotherapy for breast cancer. Clinical Nutrition ESPEN. Amsterdam: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clnesp.2020.09.775. Acesso em: 11 jun. 2024. , 2020
APA
Rufato, S. C., Silva, B. R. da, Cruz, L. P. da, Mialich, M. S., Gozzo, T. de O., & Jordão, A. A. (2020). Evaluation of food intake in women in chemotherapy for breast cancer. Clinical Nutrition ESPEN. Amsterdam: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.clnesp.2020.09.775
NLM
Rufato SC, Silva BR da, Cruz LP da, Mialich MS, Gozzo T de O, Jordão AA. Evaluation of food intake in women in chemotherapy for breast cancer [Internet]. Clinical Nutrition ESPEN. 2020 ; 40 662-663.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.clnesp.2020.09.775
Vancouver
Rufato SC, Silva BR da, Cruz LP da, Mialich MS, Gozzo T de O, Jordão AA. Evaluation of food intake in women in chemotherapy for breast cancer [Internet]. Clinical Nutrition ESPEN. 2020 ; 40 662-663.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.clnesp.2020.09.775
Trabalho de evento-resumo periodico
Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital (2020)
Pimentel, F. F.; Borba, Jéssica Maria Camargo; Rodrigues, T. C. G. F.; Peruchi, K. P. I.; Carrara, Helio Humberto Angotti ; Andrade, J. M.; Reis, Francisco José Candido dos
Source: Annals of Oncology. Conference titles: European Society for Medical Oncology Congress - ESMO. Unidade: FMRP
Subjects: QUIMIOTERAPIA, NEOPLASIAS MAMÁRIAS, PANDEMIAS, COVID-19, SEGURANÇA DO PACIENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL, F. F. et al. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.annonc.2020.08.1811. Acesso em: 11 jun. 2024. , 2020
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M., & Reis, F. J. C. dos. (2020). Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.annonc.2020.08.1811
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM, Reis FJC dos. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital [Internet]. Annals of Oncology. 2020 ; 31 S1020.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.annonc.2020.08.1811
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM, Reis FJC dos. Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital [Internet]. Annals of Oncology. 2020 ; 31 S1020.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.annonc.2020.08.1811
Trabalho de evento-resumo periodico
Assessment of nutritional risk, phase angle, and metabolic syndrome in a cohort of women with early breast cancer undergoing chemotherapy (2020)
Silva, Bruna Ramos da ; Mialich, Mirele Savegnago; Cruz, L. P. da; Rufato, Sarah Carreira; Gozzo, Thais de Oliveira ; Jordão Junior, Alceu Afonso
Source: Clinical Nutrition ESPEN. Conference titles: ESPEN Virtual Congress on Clinical Nutrition & Metabolism. Unidades: FMRP, EERP
Subjects: NUTRIÇÃO, ESTADO NUTRICIONAL, METABOLISMO, MULHERES, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Bruna Ramos da et al. Assessment of nutritional risk, phase angle, and metabolic syndrome in a cohort of women with early breast cancer undergoing chemotherapy. Clinical Nutrition ESPEN. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clnesp.2020.09.584. Acesso em: 11 jun. 2024. , 2020
APA
Silva, B. R. da, Mialich, M. S., Cruz, L. P. da, Rufato, S. C., Gozzo, T. de O., & Jordão Junior, A. A. (2020). Assessment of nutritional risk, phase angle, and metabolic syndrome in a cohort of women with early breast cancer undergoing chemotherapy. Clinical Nutrition ESPEN. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.clnesp.2020.09.584
NLM
Silva BR da, Mialich MS, Cruz LP da, Rufato SC, Gozzo T de O, Jordão Junior AA. Assessment of nutritional risk, phase angle, and metabolic syndrome in a cohort of women with early breast cancer undergoing chemotherapy [Internet]. Clinical Nutrition ESPEN. 2020 ; 40 601.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.clnesp.2020.09.584
Vancouver
Silva BR da, Mialich MS, Cruz LP da, Rufato SC, Gozzo T de O, Jordão Junior AA. Assessment of nutritional risk, phase angle, and metabolic syndrome in a cohort of women with early breast cancer undergoing chemotherapy [Internet]. Clinical Nutrition ESPEN. 2020 ; 40 601.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.clnesp.2020.09.584
Artigo de periodico
Survivin modulation in the antimelanoma activity of prodiginines (2020)
Branco, Paola Cristina; Pontes, Cristine A. ; Teixeira, Paula Rezende ; Rigo, Pep Amengual ; Fernandes, Débora Kristina Alves ; Maria-Engler, Silvya Stuchi ; Silva, Alison Batista da ; Pessoa, Otilia Deusdênia Loiola ; Jimenez, Paula C. ; Mollasalehi, Niloufar ; Chapman, Eli ; Guallar, Victor ; Machado Neto, João Agostinho ; Lotufo, Leticia Veras Costa
Source: European Journal of Pharmacology. Unidades: BIOTECNOLOGIA, FCF, ICB
Subjects: PROTEÍNAS, APOPTOSE, MELANOMA, METASTASE NEOPLÁSICA, QUIMIOTERAPIA, PRODUTOS NATURAIS, CITOTOXICIDADE IMUNOLOGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCO, Paola Cristina et al. Survivin modulation in the antimelanoma activity of prodiginines. European Journal of Pharmacology, v. 888, p. 1-10 art. 173465, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173465. Acesso em: 11 jun. 2024.
APA
Branco, P. C., Pontes, C. A., Teixeira, P. R., Rigo, P. A., Fernandes, D. K. A., Maria-Engler, S. S., et al. (2020). Survivin modulation in the antimelanoma activity of prodiginines. European Journal of Pharmacology, 888, 1-10 art. 173465. doi:10.1016/j.ejphar.2020.173465
NLM
Branco PC, Pontes CA, Teixeira PR, Rigo PA, Fernandes DKA, Maria-Engler SS, Silva AB da, Pessoa ODL, Jimenez PC, Mollasalehi N, Chapman E, Guallar V, Machado Neto JA, Lotufo LVC. Survivin modulation in the antimelanoma activity of prodiginines [Internet]. European Journal of Pharmacology. 2020 ; 888 1-10 art. 173465.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173465
Vancouver
Branco PC, Pontes CA, Teixeira PR, Rigo PA, Fernandes DKA, Maria-Engler SS, Silva AB da, Pessoa ODL, Jimenez PC, Mollasalehi N, Chapman E, Guallar V, Machado Neto JA, Lotufo LVC. Survivin modulation in the antimelanoma activity of prodiginines [Internet]. European Journal of Pharmacology. 2020 ; 888 1-10 art. 173465.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173465
Artigo de periodico
Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma (2020)
Goto, Renata Nishida; Sobral, Lays Martin; Padovani, Karina Stringhetta; Garcia, Cristiana Bernadelli ; Silva, Gabriel da; Vitek, Michael P.; Leopoldino, Andréia Machado
Source: European Journal of Pharmacology. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, FARMACOLOGIA, CARCINOMA DE CÉLULAS ESCAMOSAS, QUIMIOTERAPIA, METABOLISMO, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, SINERGISMO DE DROGAS, NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOTO, Renata Nishida et al. Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma. European Journal of Pharmacology, v. 882, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173268. Acesso em: 11 jun. 2024.
APA
Goto, R. N., Sobral, L. M., Padovani, K. S., Garcia, C. B., Silva, G. da, Vitek, M. P., & Leopoldino, A. M. (2020). Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma. European Journal of Pharmacology, 882. doi:10.1016/j.ejphar.2020.173268
NLM
Goto RN, Sobral LM, Padovani KS, Garcia CB, Silva G da, Vitek MP, Leopoldino AM. Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma [Internet]. European Journal of Pharmacology. 2020 ; 882[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173268
Vancouver
Goto RN, Sobral LM, Padovani KS, Garcia CB, Silva G da, Vitek MP, Leopoldino AM. Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma [Internet]. European Journal of Pharmacology. 2020 ; 882[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173268
Artigo de periodico
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study (2020)
Gruenwald, Viktor; Chirovsky, Diana; Cheung, Winson Y; Bertolini, Federica; Ahn, Myung-Ju; Yang, Muh-Hwa; Castro Junior, Gilberto de Castro ; Berrocal, Alfonso; Sjoquist, Katrin
Source: Oral oncology. Unidade: FM
Subjects: QUIMIOTERAPIA, CONDUTAS NA PRÁTICA DOS MÉDICOS, RECIDIVA, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRUENWALD, Viktor et al. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study. Oral oncology, v. 102, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.104526. Acesso em: 11 jun. 2024.
APA
Gruenwald, V., Chirovsky, D., Cheung, W. Y., Bertolini, F., Ahn, M. -J., Yang, M. -H., et al. (2020). Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study. Oral oncology, 102. doi:10.1016/j.oraloncology.2019.104526
NLM
Gruenwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn M-J, Yang M-H, Castro Junior G de C, Berrocal A, Sjoquist K. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study [Internet]. Oral oncology. 2020 ; 102[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.104526
Vancouver
Gruenwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn M-J, Yang M-H, Castro Junior G de C, Berrocal A, Sjoquist K. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of the GLANCE H&N study [Internet]. Oral oncology. 2020 ; 102[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.104526
Artigo de periodico
The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer (2019)
Marchi, Pedro De; Melendez, Matias E; Laus, Ana C; Kuhlmann, Pamela A; Carvalho, Ana Carolina de; Arantes, Lidia Maria R. B; Evangelista, Adriane F; Andrade, Edilene S; Castro Junior, Gilberto de Castro ; Reis, Rui M
Source: Oral oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, POLIMORFISMO, CARCINOMA DE CÉLULAS ESCAMOSAS, SEQUENCIAMENTO GENÉTICO, QUIMIOTERAPIA, ANTINEOPLÁSICOS, PROTEÍNAS DE TRANSPORTE, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHI, Pedro De et al. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, v. 98, p. 48-52, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.09.013. Acesso em: 11 jun. 2024.
APA
Marchi, P. D., Melendez, M. E., Laus, A. C., Kuhlmann, P. A., Carvalho, A. C. de, Arantes, L. M. R. B., et al. (2019). The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, 98, 48-52. doi:10.1016/j.oraloncology.2019.09.013
NLM
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
Vancouver
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration